AlphaRose Therapeutics is a startup based in the United States, 3 tracked investors.
AlphaRose Therapeutics is a company headquartered in the United States. Brouky records 3 investors associated with the company.
AlphaRose Therapeutics develops and commercializes genetic medicines for rare pediatric diseases, aiming to scale treatments for children suffering from genetic conditions with few existing therapies.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.